Bevacizumab Radioimmunotherapy (RIT) with Accelerated Blood Clearance Using the Avidin Chase-Reference-Cited by-同舟云学术

Bevacizumab Radioimmunotherapy (RIT) with Accelerated Blood Clearance Using the Avidin Chase

Published:2018-05-07 Issue:6 Volume:15 Page:2165-2173
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Yudistiro Ryan,Hanaoka Hirofumi^ORCID,Katsumata Natsumi,Yamaguchi Aiko,Tsushima Yoshito¹

Affiliation:

1. Research Program for Diagnostic and Molecular Imaging, Division of Integrated Oncology Research, Gunma University Initiative for Advanced Research (GIAR), 3-39-22 Showa, Maebashi 371-8511, Japan

Funder

Japan Society for the Promotion of Science

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.8b00027

Reference43 articles.

1. Radioimmunotherapy of Solid Tumors: Searching for the Right Target

2. Radioimmunotherapy of human tumours

3. Vascular endothelial growth factor (VEGF) and its receptors

4. Hallmarks of Cancer: The Next Generation

5. In Vivo VEGF Imaging with Radiolabeled Bevacizumab in a Human Ovarian Tumor Xenograft

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approaches to Reducing Normal Tissue Radiation from Radiolabeled Antibodies;Pharmaceuticals;2024-04-16

2. Theranostic role of 89Zr- and 177Lu-labeled aflibercept in breast cancer;European Journal of Nuclear Medicine and Molecular Imaging;2023-12-23

3. Therapeutic Characterization of 131I-Labeled Humanized Anti-B7-H3 Antibodies for Radioimmunotherapy for Glioblastoma;Engineering;2023-06

4. Nanomedicine embraces cancer radio-immunotherapy: mechanism, design, recent advances, and clinical translation;Chemical Society Reviews;2023

5. Comparative evaluation of radionuclide therapy using 90Y and 177Lu;Annals of Nuclear Medicine;2022-11-09